# A Study in Patients With Mixed Dyslipidemia

> **NCT06497127** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Shanghai Argo Biopharmaceutical Co., Ltd.** · enrollment: 145 (actual)

## Conditions studied

- Mixed Dyslipidemia

## Interventions

- **DRUG:** BW-00112

## Key facts

- **NCT ID:** NCT06497127
- **Lead sponsor:** Shanghai Argo Biopharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-02-28
- **Primary completion:** 2026-06-30
- **Final completion:** 2028-03-30
- **Target enrollment:** 145 (ACTUAL)
- **Last updated:** 2026-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06497127

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06497127, "A Study in Patients With Mixed Dyslipidemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06497127. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*